10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3,N+) versus lymph node-negative (pT2-3,N0) prostate cancer.
Rubin, M A
10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3,N+) versus lymph node-negative (pT2-3,N0) prostate cancer. [electronic resource] - Human pathology Apr 2000 - 504-8 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0046-8177
10.1053/hp.2000.6713 doi
Adenocarcinoma--genetics
Chromosomes, Human, Pair 10--genetics
Humans
Loss of Heterozygosity
Lymph Nodes--pathology
Lymphatic Metastasis--genetics
Male
Prostatic Neoplasms--genetics
10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3,N+) versus lymph node-negative (pT2-3,N0) prostate cancer. [electronic resource] - Human pathology Apr 2000 - 504-8 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0046-8177
10.1053/hp.2000.6713 doi
Adenocarcinoma--genetics
Chromosomes, Human, Pair 10--genetics
Humans
Loss of Heterozygosity
Lymph Nodes--pathology
Lymphatic Metastasis--genetics
Male
Prostatic Neoplasms--genetics